Skip to main content
. 2008 Jul 8;9(7):R110. doi: 10.1186/gb-2008-9-7-r110

Table 2.

Frequency of the CRISPR locus among E. faecalis

Name Other Origin Source/reference MLST ErmR* VanR cas EF0672-3§
TX4002 OG1RF Human [8,9] 1 - - + -
TX2708 V583 Clinical isolate [6] 6 + + - +
TX2144 E1840 Clinical isolate Ruiz-Garbajosa P.# 40 + - + -
TX2135 E1795 Hospital survey Ruiz-Garbajosa P. 44 - - - +
TX2137 E1798 Hospital survey Ruiz-Garbajosa P. 16 + - + -
TX2141 E1825 Clinical isolate Ruiz-Garbajosa P. 25 - - - +
TX2140 E1803 Hospital survey Ruiz-Garbajosa P. 38 - - - +
TX2138 E1801 Hospital survey Ruiz-Garbajosa P. 48 - - - +
TX2146 E1844 Clinical isolate Ruiz-Garbajosa P. 61 - - - +
TX2139 E1802 Hospital survey Ruiz-Garbajosa P. 35 + - + -
TX4240 A0826 Pig Jensen L. 98 + - + -
TX4247 E1876 Pig Gaastra W. 20 + - + -
TX4245 E1872 Dog Gaastra W. 16 + - + -
TX4243 E0252 Calf Mevius D. 23 + + - +
TX4255 A0808 Clinical isolate Kawalec M. 88 - - - +
TX4259 A1006 Clinical isolate Kawalec M. 135 - - - +

*Erythromycin resistance was tested at 5 μg/ml. Vancomycin resistance was tested at 10 μg/ml. Two sets of primers were used to detect the cas genes (cas1 and csn1). §This set of primers amplifies the junction between EF0672 and EF0673 where the CRISPR1 locus is inserted in OG1RF. CC2. # Ruiz-Garbajosa P. (Spain), Jensen L. (Denmark), Gaastra W. and Mevius D. (Netherland), and Kawalec M. (Poland).